2993 completed, 789 unknown, 512 recruiting, 390 terminated. 1381 Phase 2, 1157 Phase 1, 780 Phase 3, 766 Not applicable, 521 Phase 4.
Follow DNA Virus Infections: new trials by email Literature Review of DNA Virus Infections trials Research Report on DNA Virus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart | Phase 2 | Suspended | G&E Herbal Biotechnology Co., LTD | 102 | 2030-09-01 | 2023-09-14 |
| Assessment of Myocarditis After Replication-Deficient Smallpox Immunization JYNNEOS - Myopericarditis, Small Pox | Not yet recruiting | Womack Army Medical Center | 2350 | 2029-03-01 | 2023-12-14 | |
| Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines | Not applicable | Not yet recruiting | University of Florida | 1296 | 2027-09-15 | 2026-09-14 |
| Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV) Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections | Not applicable | Not yet recruiting | Hifas da Terra S.L. | 81 | 2027-07-01 | 2026-10-05 |
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma | Phase 1 | Recruiting | City of Hope Medical Center | 16 | 2027-04-17 | 2026-11-13 |
| Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI. CAR-T anti-CD19 COL01 - Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia, Lymphoid Malignancies | Phase 1 | Not yet recruiting | GUSTAVO SALGUERO | 12 | 2027-04-01 | 2026-10-20 |
| Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL) Asciminib, Inotuzumab ozogamicin - B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase 1 | Recruiting | Sunil G. Iyer | 45 | 2027-03-31 | 2026-11-13 |
| Efficacy and Safety of Oral Ivermectin for Genital Warts Ivermectin - Genital Warts | Not applicable | Not yet recruiting | University of Health Sciences Lahore | 90 | 2027-02-20 | 2026-11-03 |
| Metabolically Fit CD19 CAR T Cells With CD34 Selection Markers in Adults With CD19-Positive B-Cell Acute Lymphocytic Leukemia Fludarabine, Cyclophosphamide, Levetiracetam - CD19 Positive, B-ALL | Phase 1 | Not yet recruiting | Medical University of South Carolina | 18 | 2027-02-01 | 2026-11-13 |
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 35 | 2027-01-31 | 2026-10-27 |
| Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus | Phase 4 | Not yet recruiting | Eunice Dube | 2140 | 2027-01-30 | 2026-07-30 |
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, INSTI HIV - 1/2 Antibody, bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-11-09 |
| Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene Biopsy Procedure, Biospecimen Collection, Computed Tomography - Burkitt Lymphoma, Double-Expressor Lymphoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 50 | 2027-01-11 | 2026-10-14 |
| Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 52 | 2027-01-01 | 2026-09-14 |
| Study Of KITE-753 in R/R B-Cell ALL KITE-753 - B-cell Acute Lymphoblastic Leukemia | Phase 1 | Not yet recruiting | M.D. Anderson Cancer Center | 18 | 2026-12-31 | 2026-09-11 |
| Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children Zopapogene imadenovec-drba - Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis | Phase 3 | Not yet recruiting | Precigen, Inc | 15 | 2026-12-31 | 2026-10-28 |
| Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults MVA-BN-EBV, Placebo - Epstein Barr Virus (EBV) Infection | Phase 1 | Not yet recruiting | Bavarian Nordic | 15 | 2026-12-15 | 2026-10-22 |
| B-Ensure: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants Bepirovirsen - Hepatitis B | Phase 4 | Not yet recruiting | GlaxoSmithKline | 303 | 2026-12-03 | 2026-11-02 |
| A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 / Phase 2 | Not yet recruiting | BeOne Medicines | 30 | 2026-12-01 | 2026-10-26 |
Showing 20 of 5370. Sign in to see all of them.
Hepatitis B (1006) · Burkitt Lymphoma (977) · Hepatitis B, Chronic (866) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (591) · Lymphoma, Large B-Cell, Diffuse (576) · Papillomavirus Infections (568) · Lymphoma, Follicular (525) · Lymphoma, Non-Hodgkin (515) · Lymphoma, Mantle-Cell (510) · Leukemia, Lymphocytic, Chronic, B-Cell (471) · Lymphoma (471) · Lymphoma, B-Cell, Marginal Zone (458) · Lymphoma, Large-Cell, Immunoblastic (445) · Cytomegalovirus Infections (370) · Hodgkin Disease (362)
Virus Diseases (5282) · Infections (5275) · Communicable Diseases (2671) · Pathological Conditions, Signs and Symptoms (2487) · Herpesviridae Infections (2400) · Pathologic Processes (2347) · Disease Attributes (2193) · Tumor Virus Infections (2036) · Blood-Borne Infections (2027) · Digestive System Diseases (1903) · Liver Diseases (1752) · Hepatitis, Viral, Human (1711) · Hepadnaviridae Infections (1707) · Neoplasms (1679)
Cyclophosphamide (241) · entecavir (198) · Tenofovir (168) · Rituximab (122) · Etoposide (112) · peginterferon alfa-2a (111) · Vincristine (102) · Filgrastim (98) · Methotrexate (97) · Peripheral Blood Stem Cell Transplantation (96) · Cytarabine (94) · fludarabine phosphate (91) · Doxorubicin (83) · Radiotherapy (80) · Hepatitis B Vaccines (78)
GlaxoSmithKline (329) · National Cancer Institute (NCI) (186) · National Institute of Allergy and Infectious Diseases (NIAID) (182) · Merck Sharp & Dohme LLC (129) · Hoffmann-La Roche (71) · Fred Hutchinson Cancer Center (66) · Gilead Sciences (54) · M.D. Anderson Cancer Center (44) · Bristol-Myers Squibb (42) · Sanofi Pasteur, a Sanofi Company (40) · Third Affiliated Hospital, Sun Yat-Sen University (39) · Memorial Sloan Kettering Cancer Center (38) · National Taiwan University Hospital (38) · University of Washington (38) · Assistance Publique - Hôpitaux de Paris (35)
United States (2122) · China (847) · France (328) · Canada (312) · South Korea (267) · Germany (241) · United Kingdom (233) · Italy (210) · Taiwan (204) · Australia (200) · Spain (199) · Belgium (156) · Hong Kong (133) · Thailand (122) · New Zealand (120)
Liang Peng, Doctor (13) · Robert Yarchoan, M.D. (11) · Ajay Gopal (9) · Anna Wald, MD, MPH (9) · Ramya M Ramaswami, M.D. (8) · Elias Jabbour (7) · Helen E Heslop, MD (7) · Marc G Ghany, M.D. (7)
PMID 41276263, PMID 41671463, PMID 37781954, PMID 38700045, PMID 39807668, PMID 35622074, PMID 28427875, PMID 34515338, PMID 27422279, PMID 32499241, PMID 19052126, PMID 19935017, PMID 32184277, PMID 24915612, PMID 28404091, PMID 28404092, PMID 29405329, PMID 31824976, PMID 33460002, PMID 35599306, PMID 36263798, PMID 15470215, PMID 19187608, PMID 19236277, PMID 19236279, PMID 21182232, PMID 22225814, PMID 22436845, PMID 23046671, PMID 23234725, PMID 23518903, PMID 24731816, PMID 25424785, PMID 25424918, PMID 25788199, PMID 25987775, PMID 27658343, PMID 29074187, PMID 29211620, PMID 30982556, PMID 31042791, PMID 32589970, PMID 32710245, PMID 33857679, PMID 35149535, PMID 35941076, PMID 36066965, PMID 37166199, PMID 38551807, PMID 40237463
P30CA015704 (26), P30CA033572 (25), 2016 (21), 2017 (21), 2023 (20), P30CA043703 (19), 2018 (18), 2019 (18), U01CA121947 (18), 2014 (17), U10CA032102 (17), 2009 (15), P30CA006973 (14), 2015 (13), P30CA015083 (12)